**Core Concept**
Citrate is a key regulator in the glycolytic pathway, particularly in the control of glycolysis and gluconeogenesis. It acts as an allosteric inhibitor of phosphofructokinase-1 (PFK-1), a crucial enzyme in glycolysis.

**Why the Correct Answer is Right**
The correct answer is related to phosphofructokinase-1 (PFK-1). Citrate, as an allosteric inhibitor of PFK-1, binds to the enzyme and reduces its activity. This inhibition prevents the conversion of fructose-6-phosphate to fructose-1,6-bisphosphate, effectively slowing down glycolysis. The citrate molecule binds to the active site of PFK-1, altering its conformation and reducing its enzymatic activity.

**Why Each Wrong Option is Incorrect**
* **Option A:** Phosphoglycerate kinase is an enzyme involved in the conversion of 1,3-bisphosphoglycerate to 3-phosphoglycerate. Citrate does not directly affect this enzyme.
* **Option B:** Aldolase is an enzyme that catalyzes the conversion of fructose-1,6-bisphosphate to glyceraldehyde-3-phosphate and dihydroxyacetone phosphate. Citrate does not directly inhibit aldolase.
* **Option C:** Pyruvate kinase is an enzyme that catalyzes the conversion of phosphoenolpyruvate to pyruvate. Citrate does not directly affect pyruvate kinase.

**Clinical Pearl / High-Yield Fact**
The regulation of glycolysis by citrate is an important mechanism for controlling glucose metabolism in response to energy demands. Understanding this regulatory mechanism is crucial for appreciating the complex interplay between glucose, energy production, and cellular metabolism.

**Correct Answer:** C. Phosphofructokinase-1 (PFK-1)